Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve the unaudited standalone ....
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has informed the stock exchanges that its Board of Directors will meet on Friday, 1 August 2025. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 (Q1 FY26). The intimation is filed under SEBI's Listing Obligations and Disclosure Requirements Regulation 29. Signed by Vinod Mali, Company Secretary & Compliance Officer. No financial numbers or outcomes have been disclosed in this notice — it is a routine pre-results intimation.
No direct impact on shareholders or stock price from this filing alone. Investors should await the actual Q1 results on 1 August 2025 for any material data on revenue, margins, and profit.